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ItalyAbstractThe ﬁrst isolation of Catabacter hongkongensis in Italy is reported. Pleomorphic Gram-positive rods were grown in blood cultures from
samples obtained from a 55-year-old patient admitted to the intensive care unit with sepsis after he experienced massive thoracic and
abdominal trauma. The identiﬁcation was obtained by ampliﬁcation and sequencing of the 16S rRNA gene.
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E-mail: vittorio.sambri@auslromagna.itIntroductionCatabacter hongkongensis is a strictly anaerobic, catalase-positive,
motile and nonsporulating Gram-positive coccobacillus [1]. It
was ﬁrst isolated in 2007 in Hong Kong and Canada in blood
cultures from samples taken from patients with sepsis; it has
since been identiﬁed in fewer than 15 patients worldwide [1,2].
In Europe, the only report of C. hongkongensis in humans was
published in 2007 in France [3], and its genome has been re-
ported in water samples in Spain [4]. Five more C. hongkongensis
infections were recently described in Hong Kong [5]. To our
knowledge, this microorganism has never been described in Italy.Case ReportA 55-year-old man without any previous comorbidity was
admitted to the intensive care unit in Ravenna after aw Microbe and New Infect 2016; 9: 54–55
w Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
is is an open access article under the CC BY-NC-ND license (http://creativecommons.org/lice
p://dx.doi.org/10.1016/j.nmni.2015.11.011motorcycle accident, in which he experienced sternal and
humeral lesions and D4 and D9 vertebral fractures. A hy-
pertensive pneumothorax and a Glasgow Coma Score of 14/
15 were also present, accompanied by intracapsular spleen
haematoma with multiple fractures of the pelvis. Five days
later, empirical therapy with ceftazidime and gentamicin was
administered for 18 days. Four days after that, an abrupt onset
of fever (temperature >38.5°C) accompanied by clinical fea-
tures of septic shock appeared (with severe leucocytosis and
low platelet count), and the patient was provided vasoactive
amines with mechanical ventilation. No hemodialytic treat-
ment was applied. A monolateral purulent pleural suffusion
was also present on the right, as demonstrated by tomogra-
phy, and thoracic drainage was applied, with copious purulent
leakage.
Two sets of blood samples were taken for culture via a
central arterial catheter as a result of the poor condition of
peripheral veins. After 82 hours of incubation (Virtuo system;
bioMérieux, Marcy l’Étoile, France), one bottle (anaerobic)
showed growth of pleomorphic Gram-positive microorgan-
isms. Identiﬁcation by matrix-assisted laser desorption/ioniza-
tion time-of-ﬂight mass spectrometry (MALDI-TOF),
performed following standard and rapid procedures [6], failed
several times because no spectra matched with the isolate.
Identiﬁcation was achieved by 16S rRNA PCR ampliﬁcation andEuropean Society of Clinical Microbiology and Infectious Diseases
nses/by-nc-nd/4.0/)
TABLE 1. Antimicrobial susceptibility of Catabacter
hongkongensis isolate
Antimicrobial drug MIC (mg/L)
MIC breakpoint
(sensitive) (mg/L)
Benzylpenicillin 1.5 0.25
Amoxicillin 1.5 4
Amoxicillin–clavulanic acid 0.75 4
Piperacillin–tazobactam 0.125 8
Meropenem 0.125 2
Clindamycin 0.094 4
Vancomycin 0.75 2
Chloramphenicol 2 4
Metronidazole 0.16 4
MIC, minimum inhibitory concentration.
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showed 100% identity with C. hongkongensis (strain HKU16,
accession no. 115269.1). The metabolic proﬁle was evaluated
by API20A (bioMérieux), showing a similar pattern to already
published data [2]. The antimicrobial susceptibility testing was
performed by Etest and interpreted following European Com-
mittee on Antimicrobial Susceptibility Testing criteria (http://
www.eucast.org/clinical_breakpoints/). This was hampered by
the slow and difﬁcult growth of the isolate, which took over
10 days. The AST results are summarized in Table 1. After
2 weeks, empirical treatment with vancomycin and meropenem
was discontinued, and the patient recovered from sepsis.DiscussionC. hongkongensis is an environmental microorganism that may
occasionally be present in intestinal ﬂora [3,5]. Most of the
reported cases of blood infection caused by this microorganism
are connected with malignancies (either metastatic or involving
peritoneal organs) and with acute intestinal and biliary tract
inﬂammation. In our case, none of the above-reportedNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on beha
This is an open access artifavouring conditions was present before the accident, but the
patient had extensive trauma involving the area of the lower
diaphragm. Despite the wide capability of MALDI-TOF to
identify anaerobic bacteria, it is noteworthy that this technique
was unable to identify C. hongkongensis. We suggest that the use
of sequencing be considered when anaerobic microorganisms
that cannot be identiﬁed by routine technologies are isolated
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